Literature DB >> 29894433

Eccrine Porocarcinoma: New Insights and a Systematic Review of the Literature.

Azadeh Nazemi, Shauna Higgins, Reyna Swift, Gino In1, Kimberly Miller2, Ashley Wysong3.   

Abstract

BACKGROUND: Eccrine porocarcinoma (EPC) is a rare cutaneous neoplasm with high potential for morbidity and mortality. Due to its rarity, there is a paucity of data profiling diagnosis, work-up, and management.
OBJECTIVE: To consolidate reported information on demographics, diagnostics, clinical behavior, treatment modalities, and patient outcomes in EPC to provide a reference tool to optimize diagnosis and management.
METHODS: A comprehensive PubMed search was performed from 1963 to November 2017 using PRISMA guidelines. This yielded 155 articles detailing 206 cases of porocarcinoma.
RESULTS: Eccrine porocarcinoma most often presents in elderly patients on the head and neck or lower limbs. Metastatic disease at presentation is not uncommon (22%). Primary tumor location is significantly correlated with presence of metastasis (p = .038). The most common treatment is excision followed by Mohs micrographic surgery (MMS), although the outcomes after MMS were superior to those after surgical excision.
CONCLUSION: This systematic review of individual patient data reveals that all patients should have a histological diagnosis with imaging considered for high-risk cases. Primary tumor location should also be considered in diagnostic and therapeutic decision-making. Although wide local excision (WLE) is currently the first-line treatment, MMS is becoming increasingly used, with evidence indicating improved outcomes as compared to those seen with WLE.

Entities:  

Mesh:

Year:  2018        PMID: 29894433     DOI: 10.1097/DSS.0000000000001566

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  17 in total

1.  Primary Eccrine Porocarcinoma of the Breast: A Case Report and Review of Literature.

Authors:  Yi Xin Li; Mihir Gudi; Zhiyan Yan
Journal:  Case Rep Oncol Med       Date:  2022-05-31

Review 2.  Current Treatment Options for Cutaneous Adnexal Malignancies.

Authors:  Hiroyuki Goto
Journal:  Curr Treat Options Oncol       Date:  2022-03-26

3.  [Management of malignant adnexal neoplasms of the skin].

Authors:  Pia Nagel; Verena Müller; Jochen Utikal
Journal:  Hautarzt       Date:  2021-06-17       Impact factor: 0.751

4.  Unusual Presentations of Eccrine Porocarcinomas.

Authors:  Lester Juay; Ellie Choi; Jingxiang Huang; Huma Jaffar; Sue-Ann Ju Ee Ho
Journal:  Skin Appendage Disord       Date:  2021-09-08

5.  Head and Neck Porocarcinoma: SEER Analysis of Epidemiology and Survival.

Authors:  Matteo Scampa; Rastine Merat; Daniel F Kalbermatten; Carlo M Oranges
Journal:  J Clin Med       Date:  2022-04-14       Impact factor: 4.964

6.  Malignant Eccrine Porocarcinoma in Finland During 2007 to 2017.

Authors:  Anna-Stiina Meriläinen; Eero Pukkala; Tom Böhling; Virve Koljonen
Journal:  Acta Derm Venereol       Date:  2021-01-05       Impact factor: 3.875

Review 7.  Intergluteal Cleft Eccrine Porocarcinoma with Metastasis to Inguinal Region and Lung: Case Report and Review of the Literature.

Authors:  Ricardo Fernández-Ferreira; Gabriela Alvarado-Luna; Daniel Motola-Kuba; Ileana Mackinney-Novelo; Eduardo Emir Cervera-Ceballos; Román Segura-Rivera
Journal:  Case Rep Oncol       Date:  2020-12-10

Review 8.  Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Apocrine and Eccrine Differentiation.

Authors:  Iga Płachta; Marcin Kleibert; Anna M Czarnecka; Mateusz Spałek; Anna Szumera-Ciećkiewicz; Piotr Rutkowski
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923

9.  Eccrine Porocarcinoma: A Challenging Diagnostic and Therapeutic Tumoral Entity.

Authors:  Ha Mo Linh Le; Laurence Faugeras; Véronique De Moor; Caroline Fervaille; Thierry Vander Borght; Fanny Collette; Lionel D'Hondt
Journal:  Case Rep Oncol       Date:  2021-05-10

10.  Eccrine porocarcinoma: A rare case of an in situ tumor with lymph node metastases.

Authors:  Anna Catharina van den Brand; Jeffrey Damman; Floris H Groenendijk; Rick Waalboer-Spuij
Journal:  JAAD Case Rep       Date:  2019-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.